Erleva 150mg Tablet

Erleva 150mg Tablet

Therapeutic Class:
Get Quote

Erleva 150mg Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer.

Erleva 150mg Tablet should be taken on an empty stomach or should be taken one hour before or 2 hour after meal.  You should continue to take it as long as your doctor advises it. The duration of treatment varies according to your needs and response to treatment. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Salt Composition: Erlotinib
Strength: (150mg)
Pack Size: 30 Tablets
Uses: Non-small cell lung cancer Pancreatic cancer
Table Header
Salt Composition
Erlotinib
Strength
(150mg)
Pack Size
30 Tablets
Uses
Non-small cell lung cancer Pancreatic cancer
SKU 773123ceacc6 Category
DISCLAIMER
N Chimanlal Enterprises (www.pilcare.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Erleva 150mg Tablet which is also known as Erlotinib and Manufactured by Glenmark Pharmaceuticals Ltd. It is available in strength of Erleva 150mg Tablet is supplied for Tenders/ Emergency imports/ Un – licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Click to know price.

Product information is meant for

WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed
Categories
error:
×